It’s been interesting to see some doctors recently talking publicly about their skepticism and concerns with digital health when we’re used to hearing some loud voices tout its potential. Some, like John Henning Schumann in this Atlantic piece, worry that doctors are being asked to adopt technology to a point that it’s “eroding the foundational elements of the profession,” like face time with patients and nurses. Dr. Arnold Relman expressed similar skepticism about the nature of digital health on a recent edition of Science Friday.
HHS is late for some very important dates. An analysis from the American Action Forum found that HHS missed 20 of the 42 Affordable Care Act-related deadlines it faced in the two years after the bill was passed.
Some of the country’s biggest hospitals aren’t thrilled with their new Hospital Safety Scores calculated and released by the Leapfrog Group. Barnes-Jewish Hospital, Cleveland Clinic and Mount Sinai Medical Center, who all got grades of ‘C,’ have some gripes about the survey’s methodology, according to a WSJ story.
Ceptaris Therapeutics is getting another chance after the FDA rejected its cancer drug. Vivo Ventures, Palo Alto Investors, Burrill & Company, Aperture Venture Partners, Osage, BioAdvance and Third Point together invested $10 million, which the company says will allow it to work with regulators on address concerns in its application for approval.
The NIH and EPA together launched an innovation competition to encourage new designs for sensors that can be easily worn or carried to collect data on air pollutants and measure how they affect human health.